Opsens Inc V.OPS

Primary Symbol: T.OPS

Healthcare Medical Devices

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.

TSX:OPS - Post by User

Opsens Inc > Accumulation phase.

<< Previous

Bullboard Posts

Next >>

Comment by Qccity1on Mar 23, 2022 8:57pm

105 Views

Post# 34539908

RE:Accumulation phase.

Yes. As I was saying, stock price is being held below 2$ as some big players are waiting for the FDA approval to go all in. The quality of the new device and the efficiency gained by cardiologists will probably precipitate an earlier approval... My opinion and hope!

<< Previous

Bullboard Posts

Next >>

Canadian rare earths stock up as drilling starts at uranium property